CEDOC CHRONIC DISEASES FCM NOVA

#sliderCaption1

#sliderCaption2

#sliderCaption3

#sliderCaption4

#sliderCaption5

#sliderCaption6

#sliderCaption7

#sliderCaption8

#sliderCaption9

&nbsp

&nbsp

&nbsp

&nbsp

&nbsp

&nbsp

&nbsp

&nbsp

Biomedical and Clinical Research

Events

News

Two major contribuitions from Cláudia Almeida's Lab to Alzheimer research
Michel Kranendonk part of new consensus statement regarding Drug Induced Liver Injury
CEDOC joins consortium aiming to fight inequalities in health access worldwide
O. Vieira & R.Mathiesen Labs | Novel lipid-based methodology and the potential in diagnosis of chronic diseases
New research from CEDOC reports on antibody levels after 6 months of the Covid-19 vaccine

Publication Highlights

Conde J. & GBD 2019 Under-5 Mortality Collaborators. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. Lancet. 2021 Aug 17:S0140-6736(21)01207-1.

Perdigão C, Barata MA, Burrinha T, Almeida CG. Alzheimer's disease BIN1 coding variants increase intracellular Aβ levels by interfering with BACE1 recycling. J Biol Chem. 2021 Aug 7:101056.

Sousa L, Guarda M, Meneses MJ, Macedo MP, Vicente Miranda H. Insulin-degrading enzyme: an ally against metabolic and neurodegenerative diseases. J Pathol. 2021 Aug 16.